Has Narine Viruni, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,307 in general payments to Narine Viruni, MD across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Narine Viruni, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Narine Viruni, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Narine Viruni, MD

Ophthalmology · Colorado Springs, CONPI 1982016531

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,200 of the $6,307 with a category attached, or 82.4%. AbbVie accounts for 88.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $5,510 and has fallen 88.8% since, to $615 in 2025.

$6,307in general payments, 2019–2025

Across 16 payments — averaging $394.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$6K
Genentech USA, Inc.$259
Apellis Pharmaceuticals, Inc.$165
Amgen$146
Alcon$141

What the payments were for

Consulting fees$5,20082%
Travel & lodging$941%
Food & beverage$1,01416%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	9	$5,597
Genentech USA, Inc.	2	$259
Apellis Pharmaceuticals, Inc.	2	$165
Amgen	2	$146
Alcon	1	$141

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OZURDEX$5,200
VABYSMO$259
Unity$141

How this compares

$6,307 in reported general payments places this provider in the 85th percentile of 262 ophthalmology providers in Colorado.

See all ophthalmology providers in Colorado →

Medicare billing

Part B allowed, 2024

$1,333,152

Medicare patients

510

Services billed

7,903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	161	$5,231
Ciprofloxacin Hcl	126	$1,558
Ketorolac Tromethamine	32	$750
Dorzolamide Hcl	23	$482
ErythromycinErythromycin Base	33	$387
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	19	$300
Latanoprost	18	$173
Brimonidine Tartrate	19	$72

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Colorado Springs

Steven DeweyColorado Springs$246K
Charles McMahonColorado Springs$47K
James LeeColorado Springs$27K
James BurdenColorado Springs$24K
Matthew ChangColorado Springs$10K
Ryan RichColorado Springs$7K
Jason NobleColorado Springs$6K
John RobertsColorado Springs$4K
Jackson GoldbergColorado Springs$4K
Garrett RotaColorado Springs$3K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →